Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Aggressive Cancer Behavior of Latent Gleason Pattern 5 in Prostatectomy Specimens

TETSUYA FUJIMURA, HIROSHI FUKUHARA, YUTA YAMADA, SATORU TAGUCHI, TORU SUGIHARA, AYA NIIMI, MASAKI NAKAMURA, TOHRU NAKAGAWA, YASUHIKO IGAWA, YUKIO HOMMA and HARUKI KUME
Anticancer Research November 2018, 38 (11) 6529-6535; DOI: https://doi.org/10.21873/anticanres.13018
TETSUYA FUJIMURA
1Department of Urology, Jichi Medical University, Tochigi, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: tfujimura@jichi.ac.jp
HIROSHI FUKUHARA
2Department of Urology, Kyorin University, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUTA YAMADA
3Department of Urology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SATORU TAGUCHI
2Department of Urology, Kyorin University, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TORU SUGIHARA
1Department of Urology, Jichi Medical University, Tochigi, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AYA NIIMI
3Department of Urology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MASAKI NAKAMURA
3Department of Urology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOHRU NAKAGAWA
4Department of Urology, Teikyo University School of Medicine, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YASUHIKO IGAWA
5Department of Urology, Japan Red Cross Hospital, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUKIO HOMMA
5Department of Urology, Japan Red Cross Hospital, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HARUKI KUME
3Department of Urology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Prostate-specific antigen (PSA) relapse-free curves in patients who underwent robot-assisted radical prostatectomy (n=605). PSA relapse-free survival rates in patients with Gleason pattern (GP) 5 negative (dotted line, n=381), those with latent GP5 (black line, n=155), and those with GP5 (gray line, n=69). The PSA relapse-free survival rate was significantly worse in patients with GP5 than those without GP5 (p<0.0001), and was almost similar in latent GP5 and GP5 groups at the end of the follow-up period.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Prostate-specific antigen (PSA) relapse-free curves in low- and intermediate-risk patients. PSA-relapse in patients with latent GP5 was significantly lower compared with those to GP5-negative (p<0.0001).

Tables

  • Figures
  • Table I.
  • Table II.
  • Table III.
  • Table IV.
PreviousNext
Back to top

In this issue

Anticancer Research: 38 (11)
Anticancer Research
Vol. 38, Issue 11
November 2018
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Aggressive Cancer Behavior of Latent Gleason Pattern 5 in Prostatectomy Specimens
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Aggressive Cancer Behavior of Latent Gleason Pattern 5 in Prostatectomy Specimens
TETSUYA FUJIMURA, HIROSHI FUKUHARA, YUTA YAMADA, SATORU TAGUCHI, TORU SUGIHARA, AYA NIIMI, MASAKI NAKAMURA, TOHRU NAKAGAWA, YASUHIKO IGAWA, YUKIO HOMMA, HARUKI KUME
Anticancer Research Nov 2018, 38 (11) 6529-6535; DOI: 10.21873/anticanres.13018

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Aggressive Cancer Behavior of Latent Gleason Pattern 5 in Prostatectomy Specimens
TETSUYA FUJIMURA, HIROSHI FUKUHARA, YUTA YAMADA, SATORU TAGUCHI, TORU SUGIHARA, AYA NIIMI, MASAKI NAKAMURA, TOHRU NAKAGAWA, YASUHIKO IGAWA, YUKIO HOMMA, HARUKI KUME
Anticancer Research Nov 2018, 38 (11) 6529-6535; DOI: 10.21873/anticanres.13018
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Conclusion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Role of 1p/19q Codeletion in Diffuse Low-grade Glioma Tumour Prognosis
  • Identification of Patients With Glioblastoma Who May Benefit from Hypofractionated Radiotherapy
  • Optimal Treatment of Hormone Receptor-positive Advanced Breast Cancer Patients With Palbociclib
Show more Clinical Studies

Similar Articles

Keywords

  • Biochemical recurrence
  • Gleason score
  • Prostate cancer
  • prognosis
  • robot-assisted radical prostatectomy
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire